Prospective evaluation of the contribution of K-ras mutational analysis and CA 19.9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  European Journal of Cancer

• Publication date

  2000-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0959-8049(00)00288-4PMID 11044643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve

  1999cited by this paper
• [Accuracy of imaging techniques and tumor markers in the diagnosis of pancreatic cancer].

  1999cited by this paper
• K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.

  1999cited by this paper
• Prognostic value of CA 19-9 serum course in pancreatic cancer.

  1998cited by this paper
• K-ras gene mutations in the diagnosis of fine-needle aspirates of pancreatic masses: prospective study using two techniques with different detection limits.

  1998cited by this paper
• Ki-ras mutations and the carcinoembryonic antigen level in fine needle aspirates of the pancreas.

  1997cited by this paper
• Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice.

  1997cited by this paper
• Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses.

  1996cited by this paper
• Detection of K-ras point mutation at codon 12 in pure pancreatic juice collected 3 years and 6 months before the clinical diagnosis of pancreatic cancer.

  1996cited by this paper
• Detection of K‐ras Point Mutations at Codon 12 in Pure Pancreatic Juice for the Diagnosis of Pancreatic Cancer by PCR‐RFLP Analysis

  1996cited by this paper
• Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.

  1996cited by this paper
• Identification of K-ras Mutations in Pancreatic Juice in the Early Diagnosis of Pancreatic Cancer

  1995cited by this paper
• Application of ERCP and endoscopic tissue sampling techniques in the detection of pancreatic neoplasms

  1994cited by this paper
• Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.

  1994cited by this paper
• Diagnosis of pancreatic adenocarcinoma by polymerase chain reaction from pancreatic secretions.

  1994cited by this paper
• Pancreatic cancer in europe: Ki‐ras gene mutation pattern shows geographical differences

  1994cited by this paper
• Detection of point mutations in the K‐ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma

  1994cited by this paper
• Ki-ras mutations in pancreatic secretions and aspirates from two patients without pancreatic cancer.

  1994cited by this paper
• Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation.

  1993cited by this paper
• Pancreatic biopsy: striving for excellence.

  1993cited by this paper
• Ki-ras oncogene activation in preinvasive pancreatic cancer.

  1992cited by this paper
• Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma. The endoscopic retrograde intraductal catheter aspiration cytologic technique

  1992cited by this paper
• Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.

  1991cited by this paper
• Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas.

  1990cited by this paper
• The clinical utility of the CA 19-9 tumor-associated antigen.

  1990cited by this paper
• Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.

  1989cited by this paper
• The evaluation of CA 19‐9 antigen level in the early detection of pancreatic cancer: A prospective study of 866 patients

  1988cited by this paper
• CA 19‐9 and pancreatic adenocarcinoma

  1986cited by this paper
• Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer.

  1986cited by this paper

• Telomerase activity in pancreatic juice differentiates pancreatic cancer from chronic pancreatitis: A meta-analysis.

  2016cites this paper
• CA 19-9 and pancreatic cancer.

  2013cites this paper
• Reviewand Pancreatic Cancer

  2013cites this paper
• CA 19-9 tumor marker: is it reliable? A case report in a patient with pancreatic cancer.

  2013cites this paper
• Diagnostic accuracy of K-ras mutation for pancreatic carcinoma: a meta-analysis.

  2013cites this paper
• Pancreatic Cancer Genetics

  2012cites this paper
• Genetic and epigenetic markers in the evaluation of pancreatic masses

  2012cites this paper
• How useful is it clinically to analyse the K‐ras mutational status for the diagnosis of exocrine pancreatic cancer? A systematic review and meta‐analysis

  2011cites this paper
• [Strategies for screening for pancreatic adenocarcinoma in high-risk patients].

  2011cites this paper
• [Strategies for screening for pancreatic adenocarcinoma in high-risk patients: the place of endoscopic ultrasound].

  2011cites this paper
• Stratégies de dépistage de l’adénocarcinome pancréatique chez les patients à haut risque

  2011cites this paper
• Current Clinical Pathology

  2010cites this paper
• Wetenschappelijke ondersteuning van het College voor Oncologie

  2009cites this paper
• Genetic alterations in precancerous pancreatic lesions and their clinical implications.

  2009cites this paper
• Les altérations génétiques dans les lésions précancéreuses pancréatiques et leurs implications en clinique

  2009cites this paper
• JPN (Japan Pancreas Society) guidelines for the management of pancreatic cancer

  2009cites this paper
• CA 19-9

  2006cites this paper
• Specialized DNA Arrays for the Differentiation of Pancreatic Tumors

  2005cites this paper
• The role of preoperative biopsy in pancreatic cancer.

  2004cites this paper
• Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience.

  2004cites this paper
• Wie viel Diagnostik ist beim Pankreaskarzinom nötig?

  2003cites this paper
• Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

  2003cites this paper
• [How much diagnostics in patients with pancreatic cancer?].

  2003cites this paper
• Emerging molecular markers of cancer

  2002cites this paper
• [Molecular pathways of pancreatic carcinogenesis].

  2002cites this paper
• Intérêt des marqueurs génétiques pour le diagnostic du cancer pancréatique : Cancer du pancréas exocrine

  2001cites this paper